Raj S. Pruthi

Equibles does not estimate personal net worth.

Get an email with a short summary when enGene Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.

Get ENGN alerts

About Raj S. Pruthi

The proxy statement of enGene Therapeutics Inc. reports total compensation of $2,466,059 for Raj S. Pruthi in fiscal 2024, including a base salary of $253,483. enGene Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at enGene Therapeutics Inc. includes Ron Cooper (CEO and Board Member), Ronald H. W. Cooper (CEO and Board Member), Ronald H.W. Cooper (CEO and Board Member) and 7 others.

Affiliation history

enGene Therapeutics Inc. (ENGN)
Proxy statement

Current

Company network

enGene Therapeutics Inc.

ENGN

Current role

Biotechnology · Healthcare

Leadership on record at enGene Therapeutics Inc.

Ron Cooper CEO, Board Member
Ronald H. W. Cooper CEO, Board Member
Ronald H.W. Cooper CEO, Board Member
Ryan Daws CFO
Alex Nichols COO
Alexander Nichols COO
Dr. Alex Nichols COO
Anthony Cheung CTO
Joan Connolly CTO
Dr. William Grossman Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	enGene Therapeutics Inc. (ENGN)	MD, MHA, FACS Chief Medical Officer	$253,483	—	—	$2,005,951	$200,320	$6,305	$2,466,059

Recent activity

No call appearances or filed executive changes recorded yet.